CN100548339C - The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity - Google Patents
The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity Download PDFInfo
- Publication number
- CN100548339C CN100548339C CNB2007100625455A CN200710062545A CN100548339C CN 100548339 C CN100548339 C CN 100548339C CN B2007100625455 A CNB2007100625455 A CN B2007100625455A CN 200710062545 A CN200710062545 A CN 200710062545A CN 100548339 C CN100548339 C CN 100548339C
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine preparation
- prescription
- retinal hemorrhage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to treat the Chinese medicine of ophthalmic diseases, especially a kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity.It is made up of the crude drug of following parts by weight: Radix Salviae Miltiorrhizae 30, Radix Puerariae 15, Semen Cassiae 15, Semen Cuscutae 15, Pollen Typhae 10, Rhizoma Atractylodis 10, Sargassum 10, Thallus Laminariae (Thallus Eckloniae) 10, Radix Scutellariae 6, Radix Notoginseng powder 2.Compare with the patent ZL03104746.7 that the inventor formerly obtains, deducted Concha Haliotidis, Concha Margaritifera, Radix Cyathulae three flavor Chinese medicines among the former side in this medicine prescription, increased the Radix Puerariae Herba indigoferae Pseudotinctoriae, and the parts by weight of the Chinese medicine of respectively distinguishing the flavor of in the prescription are adjusted.Modern pharmacological research shows that puerarin contains Flavonoid substances, and the energy microcirculation improvement strengthens erythrocyte deformability, and aggregation reduces, and speeds velocity of blood flow, improves local little blood flow, anticoagulant.Therefore, this medicine prescription is more scientific and reasonable, and by clinical observation over 4 years, curative effect is more remarkable.
Description
Technical field:
The present invention relates to treat the Chinese medicine of ophthalmic diseases, especially a kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity.
Background technology:
Vitreous hemorrhage is an ophthalmology common disease, has a strong impact on vision.Because the no blood vessel of vitreous body itself, metabolism is slow, hematocele post-absorption difficulty, and especially prolonged and repeated hematocele can form proliferative vitreoretinopathy, and then causes tractional detachment of retina, therefore clinical blind rate height.The patent ZL03104746.7 that the applicant formerly obtains discloses a kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity, and through clinical observation on the therapeutic effect in the past few years, this medicine is aspect microcirculation improvement, removing hematocele, and curative effect remains further to be improved.
Summary of the invention:
The Chinese medicine preparation that the purpose of this invention is to provide a kind of treatment retinal hemorrhage vitreous opacity that curative effect is outstanding aspect microcirculation improvement, removing hematocele.
The technical scheme that realizes the foregoing invention purpose is: a kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity, form by the crude drug of following parts by weight: Radix Salviae Miltiorrhizae 30, Radix Puerariae 15, Semen Cassiae 15, Semen Cuscutae 15, Pollen Typhae 10, Rhizoma Atractylodis 10, Sargassum 10, Thallus Laminariae (Thallus Eckloniae) 10, Radix Scutellariae 6, Radix Notoginseng powder 2.
Compare with the patent ZL03104746.7 that the applicant formerly obtains, deducted Concha Haliotidis, Concha Margaritifera, Radix Cyathulae three flavor Chinese medicines among the former side in this medicine prescription, increased the Radix Puerariae Herba indigoferae Pseudotinctoriae, and the parts by weight of the Chinese medicine of respectively distinguishing the flavor of in the prescription are adjusted.Modern pharmacological research shows that puerarin contains Flavonoid substances, and the energy microcirculation improvement strengthens erythrocyte deformability, and aggregation reduces, and speeds velocity of blood flow, improves local little blood flow, anticoagulant.Therefore, this medicine prescription is more scientific and reasonable, and by observation on Clinical Application over 4 years, curative effect is more remarkable.
Following table is the applicant by the clinical observation on the therapeutic effect statistics of over 4 years 800 examples (872 eyes) patient of indication under this Chinese medicine preparation being carried out:
| Group | The eye number | Recovery from illness | Produce effects | Invalid | Total effective rate % |
| The stagnant heat type | 213 | 71 | 130 | 12 | 94.37 |
| Qi stagnation and blood stasis type | 417 | 351 | 56 | 10 | 97.60 |
| Liver-Yang sthenia type | 242 | 103 | 129 | 10 | 95.87 |
| Add up to | 872 | 525 | 315 | 32 | 95.95 |
Data declaration in the table, Chinese medicine preparation of the present invention is obvious to the therapeutic effect of retinal hemorrhage and vitreous opacity, total effective rate average out to 95.95%.
The specific embodiment:
Below provide specific embodiment of the present invention:
A kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity is made up of the crude drug of following parts by weight: Radix Salviae Miltiorrhizae 30g, Radix Puerariae 15g, Semen Cassiae 15g, Semen Cuscutae 15g, Pollen Typhae 10g, Rhizoma Atractylodis 10g, Sargassum 10g, Thallus Laminariae (Thallus Eckloniae) 10g, Radix Scutellariae 6g, Radix Notoginseng powder 2g.
Weigh the Chinese medicine of respectively distinguishing the flavor of by above-mentioned prescription, Chinese medicine reparation technology is routinely made granule then.Technological requirement:, should choose high-quality raw material of Chinese medicine for guaranteeing the curative effect of finished medicines; For guaranteeing effective extraction of volatile substance, use the totally-enclosed extraction of multi-functional extraction concentration tank; For guaranteeing that the thermal sensitivity effective ingredient is not destroyed, if empty cryoconcentration is to shorten concentration time; For guaranteeing the seriality of technical process, guarantee drug effect, in the ethanol removal process, adopt the reverse-flow type of cryogenic vacuum; For guaranteeing particulate quality, preferably use the infinitely variable speeds oscillating granulator.
The usage of above-mentioned granule: take after mixing it with water.Consumption: each 10g, every day 3 times, 12 days is a course of treatment.
Claims (1)
1, a kind of Chinese medicine preparation for the treatment of the retinal hemorrhage vitreous opacity is characterized in that said preparation is made up of the crude drug of following parts by weight: Radix Salviae Miltiorrhizae 30, Radix Puerariae 15, Semen Cassiae 15, Semen Cuscutae 15, Pollen Typhae 10, Rhizoma Atractylodis 10, Sargassum 10, Thallus Laminariae (Thallus Eckloniae) 10, Radix Scutellariae 6, Radix Notoginseng powder 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100625455A CN100548339C (en) | 2007-08-08 | 2007-08-08 | The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100625455A CN100548339C (en) | 2007-08-08 | 2007-08-08 | The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101112468A CN101112468A (en) | 2008-01-30 |
| CN100548339C true CN100548339C (en) | 2009-10-14 |
Family
ID=39021097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100625455A Expired - Fee Related CN100548339C (en) | 2007-08-08 | 2007-08-08 | The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100548339C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2865478T3 (en) * | 2014-05-23 | 2021-10-15 | Korea Inst Oriental Medicine | Pharmaceutical composition to prevent or treat macular degeneration containing natural mixture extract as active ingredient |
-
2007
- 2007-08-08 CN CNB2007100625455A patent/CN100548339C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 眼底出血的治疗方法简介. 刘文雄.中医药导报，第13卷第2期. 2007 |
| 眼底出血的治疗方法简介. 刘文雄.中医药导报，第13卷第2期. 2007 * |
| 眼血康明丸治疗视网膜静脉阻塞23例. 王文义.吉林中医药，第5期. 1998 |
| 眼血康明丸治疗视网膜静脉阻塞23例. 王文义.吉林中医药，第5期. 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101112468A (en) | 2008-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
| CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
| CN1824205B (en) | Medicine for treating chronic prostatitis and its preparation method | |
| CN101129588A (en) | Medicinal granules for conjunctivitis | |
| CN102579991B (en) | Traditional Chinese medicine composition for treating herpes simplex viral keratitis | |
| CN104043045A (en) | Pharmaceutical composition for treating optic atrophy | |
| CN100548339C (en) | The Chinese medicine preparation of treatment retinal hemorrhage vitreous opacity | |
| CN108837101B (en) | Traditional Chinese medicine ointment for treating insomnia and preparation method | |
| CN102813876A (en) | Traditional Chinese medicine for treating postpartum lochiorrhea by activating blood and removing blood stasis | |
| CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
| CN1267121C (en) | Eye disease treating medicine and its preparing process | |
| CN101062150A (en) | Wattle-proof conjunctiva beverage | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103272118A (en) | Chinese herba preparation for treating hypertension and preparation method of Chinese herba preparation | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN101229360B (en) | Anti-AIDS medicine | |
| CN101612251B (en) | Traditional Chinese medicine for treating primary liver cancer | |
| CN104096184A (en) | Traditional Chinese medicine for treating hydrocele of tunica vaginalis of children | |
| CN101129645A (en) | Anti-inflammation detoxication drink | |
| CN101693075B (en) | Traditional Chinese medicine for treating senile cataract | |
| CN102743623A (en) | Preparation method of Chinese medicine irrigation solution for treating frequent micturition and urgent micturition type trichomonas vaginitis | |
| CN102988587A (en) | Medicament for treating refractory insomnia and preparation method of medicament | |
| CN102266533A (en) | Liver softening and regenerating granules and preparation method thereof | |
| CN101129571A (en) | Oral liquid of prunella spike | |
| CN104189539A (en) | Traditional Chinese medicine for treating allergic rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091014 Termination date: 20190808 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |